Program
Time: May 08-10, 2023
Venue: Shinagawa Prince Hotel, Tokyo, Japan
Opening Ceremony and Keynote Forum
|
Opening Ceremony |
|
Time: 09:00-09:10, May 8, 2023 (Monday); Shinagawa Prince Hotel, Tokyo, Japan |
|
Keynote Forum |
|
|
Time: 09:10-11:45, May 8, 2023 (Monday); Shinagawa Prince Hotel, Tokyo, Japan |
|
|
|
|
|
Moderator |
Dr. Wolfram Carius, Executive Vice President, Bayer AG, Germany |
|
|
|
|
09:10-09:15 |
Chair’s Introduction |
|
09:15-09:45 |
Title: Homeostatic and Pathogenic Roles of Ganglioside GM3 Molecular Species Dr. Jin-ichi Inokuchi, Professor, Osaka University, Japan |
|
09:45-10:15 |
Title: How to Make the Bio Revolution a Reality? How will Bayer Become one of the Leaders in Cell and Gene Therapies? Dr. Wolfram Carius, Executive Vice President, Bayer AG, Germany |
|
10:15-10:45 |
Title: AI, Digital Revolution & New Avenues in Drug Discovery Dr. Hans Leuenberger, Professor, Department of Pharmaceutics, University of Florida, USA |
|
10:45-11:15 |
Title: Influence of Production Process Methodology and Scale on Polypeptide Drug Quality: Case study on GLP-1 Derivatives |
|
11:15-11:45 |
Title: An Unusual Metastatic Tumor To The Heart |
|
11:45-12:15 |
Title: Well-Characterization of Co-formulation of Therapeutic Antibodies |
|
GSCF 01: Basic Oncological Research |
|
|
Time: 09:00-12:20, May 09, 2023 (Tuesday); Place: Lavender, 3F, Shinagawa Prince Hotel |
|
|
|
|
|
Chair |
Dr. Rony Seger, Professor, Weizmann Institute of Science, Rehovot, Israel |
|
|
|
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:30 |
Keynote Speech Title: The Nuclear Translocation of ERK as a Therapeutic Target for Cancer Dr.. Rony Seger, Professor, Weizmann Institute of Science, Rehovot, Israel |
|
09:30-09:50 |
Title: Some Popular Machine Learning Methods Tend to Over-Select Features Dr. Sin-Ho Jung, Professor, Duke University, USA |
|
09:50-10:10 |
Title: The Role of Histone Mutations in Human Disease Dr. Kui Ming Chan, Associate Professor, City University of Hong Kong, Hong Kong, China |
|
10:10-10:30 |
Title: Identification of Predictive Factors for Early Relapse in Patients with Unresectable Stage III NSCLC Receiving Consolidation Durvalumab after Concurrent Chemoradiation Dr. Hye Seon Kang, Assistant Professor, The Catholic University of Korea, South Korea |
|
10:30-10:50 |
Title: Expression of Cancer/Testis Antigens MAGE-A and NY-ESO-1 in Tumors Dr. Antonio Juretic, School of Medicine, University of Zagreb and University Hospital "Sveti Duh",Croatia |
|
10:50-11:00 |
Coffee Break |
|
11:00-11:20 |
Title: Using Real Time Digital PCR to Improve the Sensitivity For Liquid Biopsy Dr. Yan Wang, President/CSO, Gnomegen LLC, USA |
|
11:20-11:40 |
Title: Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication |
|
11:40-12:00 |
Title: Combined Cyclin-Dependent Kinase Inhibition Overcomes MAPK/Extracellular SignaleRegulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I Dr. Zhichao Wang, Associate Professor, Department of Plastic and Reconstructive Surgery, Shanghai Jiao Tong University School of Medicine, China(Video) |
|
12:00-12:20 |
Title: A Multifunctional Peptide for Targeted Imaging and Chemotherapy For Nasopharyngeal And Breast Cancers Dr. Chin-Tarng Lin, Professor, National Taiwan University Hospital, Taiwan(Video) |
|
GSCF 02: Frontiers of Clinical Oncology |
|
|
Time: 9:00-13:00, May 10, 2023 (Wednesday); Place: Lavender, 3F, Shinagawa Prince Hotel |
|
|
|
|
|
Chair |
Dr. Christie Bialowas, Associate Professor, Albany Medical Center, USA |
|
|
|
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:25 |
Title: A Longitudinal Assessment of the Surgical Treatment of Symptomatic Neuromas and Their Reconstruction Surgical Management in the American College of Surgeons National Surgical Quality Improvement Program Database Dr. Christie Bialowas, Associate Professor, Albany Medical Center, USA |
|
09:25-09:45 |
Title: PD-L1 Alone As a Prognostic Marker in Gastroesophageal Cancer – Do We Have To Learn More? Dr. Sebastian F. Schoppmann, Head of Upper-Gi Surgery, Department of Surgery, Medical University of Vienna, Austria |
|
09:45-10:05 |
Title: Single-Institution Retrospective Analysis of Ovarian Cancer Outcomes from the Middle Eastern Republic of Georgia Dr. Nino Vardiashvili, Innova Medical Center, Georgia |
|
10:05-10:25 |
Title: Left Atrial Myxoma Presenting as Cerebral Embolism Dr. Hemant Digambar Waikar, Chief Cardiac Anaesthetist, Nawaloka Hospita, Sri Lanka |
|
10:25-10:45 |
Title: Person-centered Palliative Care In Long Term Care Settings: Measuring Well-Dying As a Patient Reported Outcome Dr. So-Hi Kwon, Professor, Kyungpook National University, College of Nursing, South Korea |
|
10:45-11:00 |
Coffee Break |
|
11:00-11:20 |
Title: Evolving Use of Breast Cancer Biomarkers in Personalized Cancer Care: The Role of the Pathologist Dr. Constance T. Albarracin, Pathologist Tenured Professor, The University of Texas MD Anderson Cancer Center, USA |
|
11:20-11:40 |
Title: Neuroendocrine Neoplasm of the Breast: An Evolving Diagnostic Entity |
|
11:40-12:00 |
Title: Gastric-Type Cervical Adenocarcinoma: Diagnosis and Ancillary Testing Dr. Preetha Ramalingam, Professor, The University of Texas MD Anderson Cancer Center, USA |
|
12:00-12:20 |
Title: Cancer Therapeutic Vaccine Dr. Zhangyong Hong, Professor, Nankai University, China |
|
12:20-12:40 |
Title: Multiple Effects of Ginseng Berry Polysaccharide on Inflammation-Associated Colon Cancer Dr. Jin-Yi Wan, Associate Professor, Beijing University of Chinese Medicine, China(Video) |
|
12:40-13:00 |
Title: Gender Specific Cut-Off Levels in Population-Based Colorectal Cancer Screening with Fecal Immunochemical Test Dr. Johannes Blom, Head of Department of Surgery, Södersjukhuset, Karolinska Institutet Stockholm, Sweden |
Contact Us: Email:Mandy@bitcongress.com
Company Name: 3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road,
Hi-tech Industrial Zone, Dalian City, Liaoning Province, China
Copyright © 2008-2022 BIT Congress